InsidersTradesSigma
Explore the full record of transactions filed by Beskrovnaya Oxana, Directrice Scientifique. Insider active across 1 companies, notably Dyne Therapeutics, Inc.. Cumulatively, 6 disclosures have been published. Total volume traded: €22k. The latest transaction was filed on 14 June 2022 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
6 of 6 declarations
Oxana Beskrovnaya is the Chief Scientific Officer at Dyne Therapeutics, Inc. She oversees research and development initiatives, focusing on scientific innovation. Her role is essential in guiding research strategy and ensuring the success of development projects.